Unlearn’s First Ever Webinar Series, Powering Clinical Research with AI, is available On-Demand

Watch now

Join us at AD/PD 2021

Read our blog

Accelerating clinical trials with AI

Learn More

A new paradigm for faster trials providing rigorous clinical evidence with fewer subjects.

The Problem

Enrollment challenges, timeline delays, and high failure rates burden clinical trials. AI can change that.

What we do

Unlearn is the only company to create digital twins to populate Intelligent Control Arms in clinical studies.

Why it's unique

While others leverage existing data, Unlearn generates a new type of data, for any type of patient.

The Problem

Enrollment challenges and timeline delays plague clinical trials.

THe old way

External controls can help solve these problems, but are typically unreliable.

the new way

Twintelligent RCTs™ generate reliable evidence in a fraction of the time.

How it works

Twintelligent RCTs™ combine AI, Digital Twins, and novel statistical methods to enable smaller, more efficient trials.

Learn More

Make trials more patient-centric

Clinical trials with smaller control groups are more attractive to patients.

Shorten enrollment timelines

Twintelligent RCTs™ reach enrollment targets faster because they require fewer patients.

Increase power and confidence

Twintelligent RCTs™ provide reliable evidence suitable for pivotal clinical trials.

Publications

Machine learning for comprehensive forecasting of Alzheimer's Disease progression

September 20, 2019

We have shown that generative models capable of sampling conditional probability distributions over a diverse array of clinical variables can accurately model the...

Resources

Research, Perspectives, and Insights

View All

Press

Unlearn Appoints AstraZeneca’s Chief Medical Officer Ann E. Taylor, M.D. to Board of Directors

March 10, 2021

Podcasts

Finding Genius Podcast: AI in Healthcare: Artificial Intelligence is the Way to Advance into the Next Era of Medical Technology

February 5, 2021

Press

Unlearn.AI named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

April 7, 2021

Accelerating clinical trials with AI

It's about time.

Unlearn’s First Ever Webinar Series, Powering Clinical Research with AI, is available On-Demand

Join us at AD/PD 2021

Unlearn will present novel, AI-driven approaches to enabling smaller, more efficient Alzheimer’s clinical trials

Accelerating clinical trials with AI

It's about time.

A new paradigm for faster trials providing rigorous clinical evidence with fewer subjects.

Enrollment challenges, timeline delays, and high failure rates burden clinical trials. AI can change that.

Unlearn is the only company to create digital twins to populate Intelligent Control Arms in clinical studies.

While others leverage existing data, Unlearn generates a new type of data, for any type of patient.

Enrollment challenges and timeline delays plague clinical trials.

External controls can help solve these problems, but are typically unreliable.

Twintelligent RCTs™ generate reliable evidence in a fraction of the time.

How it works

Make trials more patient-centric

Shorten enrollment timelines

Increase power and confidence

Machine learning for comprehensive forecasting of Alzheimer's Disease progression

Resources

Research, Perspectives, and Insights

Unlearn Appoints AstraZeneca’s Chief Medical Officer Ann E. Taylor, M.D. to Board of Directors

Finding Genius Podcast: AI in Healthcare: Artificial Intelligence is the Way to Advance into the Next Era of Medical Technology

Unlearn.AI named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

Interested in a partnership?